Nerve Repair Biomaterials Market has accounted is expected to reach USD 775.59 by 2024 from USD 326.71 million in 2016 at 11.5% CAGR till 2024.

DALLAS, TEXAS, UNITED STATES, June 21, 2017 /EINPresswire.com/ -- Global Nerve Repair Biomaterials Market, By Product Type (Nerve Repair (Nerve Conduit, Nerve Graft (Allograft, Acellularized Allograft)), Nerve Protection (Nerve Protectors, Nerve Wrap), By Injury Type (Epineural Nerve Repair, Perineural Nerve Repair, Group Fascicular Repair), By End User (Hospital, Clinics, Ambulatory Trauma Centers), By Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa, Rest of the World) – Trends and Forecast to 2024

Nerve Repair Biomaterials Market has accounted for USD 326.71 million in 2016 and is expected to reach USD 775.59 by 2024 at 11.5% CAGR during the forecast year till 2024. The market contains data for the actual calculation years as 2016 , the historic years as 2015 and the forecast period from 2017 to 2024.

The market is segmented on the basis of product type, injury type, end user and geography.

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Ask for Sample of the report: http://databridgemarketresearch.com/request-a-sample/?chalet=Global%20Nerve%20Repair%20Biomaterials%20Market%20-%20Industry%20Trends%20and%20Forecast%20to%202024

Segmentation:

By Product type:

Nerve Repair
1. Nerve Conduit
2. Nerve Graft
a. Allograft
b. Acellularized Allograft
Nerve Protection
1. Nerve Protectors
2. Nerve Wrap

By Injury Type:

Body Composition Analysis
Fracture Diagnosis
Bone Densitometry
Fracture Risk Assessment

By End-User:

Hospital
Clinics
Ambulatory Trauma Centers

Read More on the market trends of Global Nerve Repair Biomaterials Market: http://databridgemarketresearch.com/global-nerve-repair-biomaterials-market-growing-significant-rate-forecast-period-2017-2024/

The major players in the Nerve Repair Biomaterials Market are Integra LifeSciences Corporation,Stryker, Collagen Matrix, Inc., AxoGen, Inc., Checkpoint Surgical, Inc., Inc., Polyganics, and Synovis Micro Companies Alliance, Inc.

Some Recent Developments:

1. STRYKER: In April 2016, Stryker Corporation announced the completion of its previously announced acquisition of Synergetics USA, Inc.’s Neuro Portfolio.

2. AXOGEN, INC.: In November 2016, AxoGen, Inc., announced the commercial release and first clinical implant of Avive Soft Tissue Membrane which is a minimally processed human umbilical cord membrane delivering the benefits of amnion to reduce inflammation and scar tissue formation.

Purchase Report: http://databridgemarketresearch.com/reports/global-nerve-repair-biomaterials-market-trends-forecast-2024/

Table Of Contents:

1. INTRODUCTION
1.1. OVERVIEW OF THE NERVE REPAIR BIOMATERIALS MARKET
1.2. MARKET SEGMENTATION & COVERAGE
1.2.1. CURRENCY AND PRICING
1.2.2. LIMITATION
1.2.3. STAKEHOLDERS
2. RESEARCH METHODOLOGY
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL NERVE REPAIR BIOMATERIALS MARKET SIZE
2.2.1. MARKET CRACKDOWN APPROACH
2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS
2.2.3. DATA TRIANGULATION
2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES
2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES
2.2.6. PORTER’S FIVE FORCES MATRIX
2.3. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3. MARKET LANDSCAPE SUMMARY
4. PREMIUM INSIGHTS
4.1. OVERVIEW
4.2. GLOBAL NERVE REPAIR BIOMATERIALS MARKET: KEY PRIMARY INSIGHTS
4.3. MARKET OVERVIEW
4.3.1. DRIVERS
4.3.1.1. INCREASING INCIDENCES OF PERIPHERAL NERVE INJURIES
4.3.1.2. TECHNOLOGICAL DEVELOPMENT IN NERVE REPAIR
4.3.1.3. FAVORABLE REIMBURSEMENT POLICIES
4.3.1.4. EXPANDED TARGET APPLICATIONS
4.3.2. RESTRAINTS
4.3.2.1. LACK OF PATIENT AWARENESS
4.3.2.2. LACK OF PROFESSIONALS, INCLUDING TRAINED SURGEONS
4.3.3. OPPURTUNITIES
4.3.3.1. NOVEL THERAPIES SUCH AS STEM CELL THERAPY
4.3.3.2. RISING ACCEPTANCE OF EMERGING MARKETS
4.3.4. THREATS
4.3.4.1. DONOR SITE MORBIDITY
4.3.4.2. INADEQUATE NERVE REGENERATION BY CONDUITS
4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES
5. EXECUTIVE SUMMARY
6. NERVE REPAIR BIOMATERIALS MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. NERVE REPAIR
6.2.1. NERVE CONDUITS
6.2.2. NERVE GRAFTS
6.2.2.1. ALLOGRAFTS
6.2.2.2. ACELLULARIZED ALLOGRAFTS
6.3. NERVE PROTECTION
6.3.1. NERVE PROTECTOR
6.3.2. NERVE WRAP
7. NERVE REPAIR BIOMATERIALS MARKET, BY INJURY TYPE
7.1. OVERVIEW
7.2. EPINEURAL NERVE REPAIR
7.3. PERINEURAL NERVE REPAIR
7.4. GROUP FASCICULAR NERVE REPAIR
8. NERVE REPAIR BIOMATERIALS MARKET, BY END USER
8.1. OVERVIEW
8.2. HOSPITALS
8.3. AMBULATORY TRAUMA CENTERS
8.4. CLINICS
9. NERVE REPAIR BIOMATERIALS MARKET, BY GEOGRAPHY
9.1. COUNTRYWISE NERVE REPAIR BIOMATERIALS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER
BY COUNTRY)
9.1.1. NORTH AMERICA
9.1.1.1. U.S.
9.1.1.2. CANADA
9.1.1.3. MEXICO
9.1.2. EUROPE
9.1.2.1. GERMANY
9.1.2.2. FRANCE
9.1.2.3. U.K.
9.1.2.4. ITALY
9.1.2.5. SPAIN
9.1.2.6. RUSSIA
9.1.2.7. TURKEY
9.1.2.8. BELGIUM
9.1.2.9. NETHERLANDS
9.1.2.10. SWITZERLAND
9.1.2.11. REST OF EUROPE
9.1.3. ASIA-PACIFIC (APAC)
9.1.3.1. JAPAN
9.1.3.2. CHINA
9.1.3.3. SOUTH KOREA
9.1.3.4. INDIA
9.1.3.5. AUSTRALIA
9.1.3.6. SINGAPORE
9.1.3.7. THAILAND
9.1.3.8. MALAYSIA
9.1.3.9. INDONESIA
9.1.3.10. PHILIPPINES
9.1.3.11. REST OF APAC
9.1.4. LATIN AMERICA
9.1.4.1. BRAZIL
9.1.4.2. REST OF LATIN AMERICA
9.1.5. MIDDLE EAST AND AFRICA
9.1.5.1. SOUTH AFRICA
9.1.5.2. REST OF MIDDLE EAST AND AFRICA
9.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
10. NERVE REPAIR BIOMATERIALS MARKET: COMPETITIVE LANDSCAPE
10.1. GLOBAL NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.2. U.S. NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.3. EUROPE NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.4. APAC NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.5. SOUTH AMERICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.6. MIDDLE EAST AND AFRICA NERVE REPAIR MARKET: COMPANY SHARE ANALYSIS
10.7. MERGERS & ACQUISITIONS
10.8. NEW PRODUCT DEVELOPMENT & APPROVALS
10.9. EXPANSIONS
10.10. REGULATORY CHANGES
10.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
11. NERVE REPAIR BIOMATERIALS MARKET, COMPANY PROFILES
11.1. AXOGEN, INC.
11.1.1. COMPANY OVERVIEW
11.1.2. SWOT ANALYSIS
11.1.3. REVENUE ANALYSIS
11.1.4. PRODUCT PORTFOLIO
11.1.5. RECENT DEVELOPEMENTS
11.1.6. DATA BRIDGE ANALYSIS
11.2. CHECKPOINT SURGICAL, INC.
11.2.1. COMPANY OVERVIEW
11.2.2. SWOT ANALYSIS
11.2.3. REVENUE ANALYSIS
11.2.4. PRODUCT PORTFOLIO
11.2.5. RECENT DEVELOPEMENTS
11.2.6. DATA BRIDGE ANALYSIS
11.3. COLLAGEN MATRIX, INC.
11.3.1. COMPANY OVERVIEW
11.3.2. SWOT ANALYSIS
11.3.3. REVENUE ANALYSIS
11.3.4. PRODUCT PORTFOLIO
11.3.5. RECENT DEVELOPEMENTS
11.3.6. DATA BRIDGE ANALYSIS
11.4. INTEGRA LIFESCIENCES CORPORATION
11.4.1. COMPANY OVERVIEW
11.4.2. SWOT ANALYSIS
11.4.3. REVENUE ANALYSIS
11.4.4. PRODUCT PORTFOLIO
11.4.5. RECENT DEVELOPEMENTS
11.4.6. DATA BRIDGE ANALYSIS
11.5. POLYGANICS B.V.
11.5.1. COMPANY OVERVIEW
11.5.2. SWOT ANALYSIS
11.5.3. REVENUE ANALYSIS
11.5.4. PRODUCT PORTFOLIO
11.5.5. RECENT DEVELOPEMENTS
11.5.6. DATA BRIDGE ANALYSIS
11.6. STRYKER CORPORATION
11.6.1. COMPANY OVERVIEW
11.6.2. SWOT ANALYSIS
11.6.3. REVENUE ANALYSIS
11.6.4. PRODUCT PORTFOLIO
11.6.5. RECENT DEVELOPEMENTS
11.6.6. DATA BRIDGE ANALYSIS
11.7. SYNOVIS MICRO COMPANIES ALLIANCE, INC.
11.7.1. COMPANY OVERVIEW
11.7.2. SWOT ANALYSIS
11.7.3. REVENUE ANALYSIS
11.7.4. PRODUCT PORTFOLIO
11.7.5. RECENT DEVELOPEMENTS
11.7.6. DATA BRIDGE ANALYSIS
12. APPENDIX
13. ABOUT DATA BRIDGE MARKET RESEARCH

Shubham Dwivedi
Data Bridge Market Research Private Ltd.
+1-888-387-2818
email us here